CRISPR gene editing
A guide RNA leads a Cas enzyme to cut DNA at a chosen spot, so genes can be changed precisely.
Health and medicine · Biotechnology · No. 200
- Networked and AI age
- Readiness 9 of 9
- Process
A defence that bacteria use against viruses became, within eleven years, a licensed medicine aimed at curing an inherited blood disease.
Chart: Illustration: CRISPR gene editing
Where it comes from
Chart: Map of where it comes from
Biologists found odd repeats in bacterial DNA, named CRISPR in 2002. By 2007 they knew it was an immune system; in 2012 Charpentier and Doudna turned its cutting enzyme into a programmable tool.
Three things to know
- CRISPR is a bacterial immune system: in 2007 experiments showed that it protects bacteria against viruses.
- Casgevy, licensed in 2023, edits a patient's own blood stem cells so the body makes working haemoglobin.
- In 2021 WHO set out how to govern human genome editing, including registries of research and a way to report concerns in confidence.
The journey
- 1 BacteriaMicrobes store snippets of virus DNA to recognise repeat attacks
- 2 DiscoveryScientists work out how the stored snippets guide a cutting enzyme
- 3 ToolIn 2012 the enzyme is shown to cut any DNA a guide RNA points to
- 4 LaboratoryFrom 2013 it edits genes in human and mouse cells
- 5 ProductsEdited crops and, from 2023, a licensed medicine for blood disorders